Skip to Content

WPI 2344 (Lacosamide 150 mg)

Pill with imprint WPI 2344 is Brown, Elliptical / Oval and has been identified as Lacosamide 150 mg. It is supplied by Actavis Pharma, Inc..

Lacosamide is used in the treatment of seizures and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 150 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2344

Lacosamide

Imprint:
WPI 2344
Strength:
150 mg
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Miscellaneous anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
5 - Some potential for abuse
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2344

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide